Year |
Citation |
Score |
2018 |
Leventhal JR, Ildstad ST. Tolerance Induction in HLA Disparate Living Donor Kidney Transplantation by Facilitating Cell-Enriched Donor Stem Cell Infusion: the importance of durable chimerism. Human Immunology. PMID 29409743 DOI: 10.1016/j.humimm.2018.01.007 |
0.301 |
|
2017 |
Chhabra AY, Leventhal J, Merchak AR, Ildstad S. HSCT-Based Approaches for Tolerance Induction in Renal Transplant. Transplantation. 101: 2682-2690. PMID 28574903 DOI: 10.1097/TP.0000000000001837 |
0.305 |
|
2013 |
Leventhal JR, Mathew JM, Ildstad S, Salomon DR, Kurian SM, Suthanthiran M, Tambur A, Friedewald J, Gallon L, Charette J, Levitsky J, Kanwar Y, Abecassis M, Miller J. HLA identical non-chimeric and HLA disparate chimeric renal transplant tolerance Clinical Transplants. 145-156. PMID 25095503 |
0.305 |
|
2013 |
Leventhal J, Miller J, Abecassis M, Tollerud DJ, Ildstad ST. Evolving approaches of hematopoietic stem cell-based therapies to induce tolerance to organ transplants: the long road to tolerance. Clinical Pharmacology and Therapeutics. 93: 36-45. PMID 23212110 DOI: 10.1038/Clpt.2012.201 |
0.302 |
|
2012 |
Leventhal J, Abecassis M, Miller J, Gallon L, Ravindra K, Tollerud DJ, King B, Elliott MJ, Herzig G, Herzig R, Ildstad ST. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Science Translational Medicine. 4: 124ra28. PMID 22399264 DOI: 10.1126/Scitranslmed.3003509 |
0.303 |
|
2011 |
Cardenas PA, Huang Y, Ildstad ST. The role of pDC, recipient T(reg) and donor T(reg) in HSC engraftment: Mechanisms of facilitation. Chimerism. 2: 65-70. PMID 22163063 DOI: 10.4161/chim.2.3.17588 |
0.322 |
|
2007 |
Colson YL, Shinde Patil VR, Ildstad ST. Facilitating cells: novel promoters of stem cell alloengraftment and donor-specific transplantation tolerance in the absence of GVHD. Critical Reviews in Oncology/Hematology. 61: 26-43. PMID 17150368 DOI: 10.1016/j.critrevonc.2006.06.011 |
0.323 |
|
2004 |
Colson YL, Xu H, Huang Y, Ildstad ST. Mixed xenogeneic chimerism induces donor-specific humoral and cellular immune tolerance for cardiac xenografts. Journal of Immunology (Baltimore, Md. : 1950). 173: 5827-34. PMID 15494536 DOI: 10.4049/jimmunol.173.9.5827 |
0.305 |
|
2004 |
Xu H, Chilton PM, Huang Y, Schanie CL, Ildstad ST. Production of donor T cells is critical for induction of donor-specific tolerance and maintenance of chimerism. Journal of Immunology (Baltimore, Md. : 1950). 172: 1463-71. PMID 14734723 DOI: 10.4049/jimmunol.172.3.1463 |
0.302 |
|
2003 |
Jacquet EG, Schanie CL, Fugier-Vivier I, Willer SS, Ildstad ST. Facilitating cells as a venue to establish mixed chimerism and tolerance. Pediatric Transplantation. 7: 348-57. PMID 14738294 DOI: 10.1034/j.1399-3046.2003.00100.x |
0.323 |
|
2001 |
Chilton PM, Huang Y, Ildstad ST. Bone marrow cell graft engineering: from bench to bedside. Leukemia & Lymphoma. 41: 19-34. PMID 11342354 DOI: 10.3109/10428190109057951 |
0.309 |
|
1999 |
Exner BG, Domenick MA, Bergheim M, Mueller YM, Ildstad ST. Clinical applications of mixed chimerism. Annals of the New York Academy of Sciences. 872: 377-85; discussion 3. PMID 10372140 DOI: 10.1111/j.1749-6632.1999.tb08482.x |
0.306 |
|
1999 |
Exner BG, Acholonu IN, Bergheim M, Mueller YM, Ildstad ST. Mixed allogeneic chimerism to induce tolerance to solid organ and cellular grafts. Acta Haematologica. 101: 78-81. PMID 10202237 |
0.304 |
|
1997 |
Exner BG, Colson YL, Li H, Ildstad ST. In vivo depletion of host CD4+ and CD8+ cells permits engraftment of bone marrow stem cells and tolerance induction with minimal conditioning Surgery. 122: 221-227. PMID 9288126 DOI: 10.1016/S0039-6060(97)90012-X |
0.311 |
|
1997 |
Jankowski RA, Ildstad ST. Chimerism and tolerance: From freemartin cattle and neonatal mice to humans Human Immunology. 52: 155-161. PMID 9077564 DOI: 10.1016/S0198-8859(96)00290-X |
0.33 |
|
1996 |
Colson YL, Li H, Boggs SS, Patrene KD, Johnson PC, Ildstad ST. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach. Journal of Immunology (Baltimore, Md. : 1950). 157: 2820-9. PMID 8816385 |
0.304 |
|
1995 |
Li H, Abou El-Ezz AY, Gambrell BE, Ildstad ST. Mixed xenogeneic chimerism and tolerance III: A nonlethal approach to induce donor-specific transplantation tolerance to simultaneous islet xenografts Transplantation. 60: 59-65. PMID 7624944 |
0.306 |
|
1995 |
Colson YL, Wren SM, Schuchert MJ, Patrene KD, Johnson PC, Boggs SS, Ildstad ST. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers. Journal of Immunology (Baltimore, Md. : 1950). 155: 4179-88. PMID 7594573 |
0.319 |
|
1995 |
Colson YL, Zadach K, Nalesnik M, Ildstad ST. Mixed allogeneic chimerism in the rat: Donor - Specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts Transplantation. 60: 971-980. PMID 7491703 |
0.304 |
|
1993 |
Cooper MH, Nalesnik MA, Watkins SC, Hoffman RA, Ildstad ST. Cross-species graft-versus-host-disease is accompanied by a donor-derived cellular immune response Transplantation. 56: 934-940. PMID 8212220 |
0.32 |
|
1992 |
Wren SM, Hronakes ML, Ildstad ST. The requirement for allogeneic chimerism for second transfer of tolerance from mixed allogeneic chimeras (A + B→A) to secondary recipients Transplantation. 54: 1031-1040. PMID 1465769 |
0.313 |
|
1991 |
Wren SM, Nalesnik M, Hronakes ML, Oh E, Ildstad ST. Mixed chimerism to induce tolerance for solid organ transplantation Journal of Pediatric Surgery. 26: 439-443. PMID 2056405 DOI: 10.1016/0022-3468(91)90992-3 |
0.311 |
|
1986 |
Ildstad ST, Wren SM, Bluestone JA, Barbieri SA, Stephany D, Sachs DH. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2 → B10) Journal of Immunology. 136: 28-33. PMID 2933464 |
0.303 |
|
Show low-probability matches. |